UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits

BMC infectious diseases, 2015-01, Vol.15 (1), p.19-19, Article 19

2015

Volltextzugriff (PDF)

Decision making by NICE: examining the influences of evidence, process and context

Health economics, policy and law, 2014-04, Vol.9 (2), p.119-141

2014

Volltextzugriff (PDF)

Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making

The European journal of health economics, 2014-09, Vol.15 (7), p.681-695

2014

Volltextzugriff (PDF)

Relative efficacy and safety of simeprevir and telaprevir in treatment-naïve hepatitis C-infected patients in a Japanese population: A Bayesian network meta-analysis

Hepatology research, 2015-10, Vol.45 (10), p.E89-E98

2015

Volltextzugriff (PDF)

Impact of Stigma on People Living with Chronic Hepatitis B

Patient related outcome measures, 2020-01, Vol.11, p.95-107

2020

Volltextzugriff (PDF)

Validation of the Fatigue Severity Scale in chronic hepatitis C

Health and quality of life outcomes, 2014-06, Vol.12 (1), p.90-90, Article 90

2014

Volltextzugriff (PDF)

Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

PharmacoEconomics, 2015-04, Vol.33 (4), p.409-422

2015

Volltextzugriff (PDF)

Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Journal of medical economics, 2015-01, Vol.18 (7), p.502-511

2015

Volltextzugriff (PDF)

Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection

BMC infectious diseases, 2014-08, Vol.14 (1), p.465-465, Article 465

2014

Volltextzugriff (PDF)

Decision making by NICE: examining the influences of evidence, process and context – CORRIGENDUM

Health economics, policy and law, 2014-10, Vol.9 (4), p.435-435

2014

Volltextzugriff (PDF)

Evidence, process or context?: examining the factors that drive coverage decisions of pharmaceuticals by health technology assessment bodies in europe

Cerri, Karin H

2011

Volltextzugriff (PDF)

Imatinib Resistance and/or Intolerance in Clinical Practice in Europe: The “Unmet Needs in CML and Ph+ALL” (UNIC) Study

Blood, 2007-11, Vol.110 (11), p.1951-1951

2007

Volltextzugriff (PDF)

Real-Life Rates of Disease Monitoring in Clinical Practice in Europe: The “Unmet Needs in CML and Ph+ALL” (UNIC) Study

Blood, 2007-11, Vol.110 (11), p.1959-1959

2007

Volltextzugriff (PDF)

Mycobacterium aviumsubsp. paratuberculosis isolated from wild red deer (Cervus elaphus) in Northern Italy

Veterinary microbiology, 2018-04, Vol.217, p.167-172

2018

Volltextzugriff (PDF)

Mycobacterium avium subsp. paratuberculosis isolated from wild red deer ( Cervus elaphus ) in Northern Italy

Veterinary microbiology, 2018-04, Vol.217, p.167-172

2018

Volltextzugriff (PDF)

Modelling and optimizing the process of learning mathematics

Intelligent Tutoring Systems, 2012, p.S. 389-398

2012

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Sprache

Englisch
(16)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits

Decision making by NICE: examining the influences of evidence, process and context

Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making

Relative efficacy and safety of simeprevir and telaprevir in treatment-naïve hepatitis C-infected patients in a Japanese population: A Bayesian network meta-analysis

Impact of Stigma on People Living with Chronic Hepatitis B

Validation of the Fatigue Severity Scale in chronic hepatitis C

Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection

Decision making by NICE: examining the influences of evidence, process and context – CORRIGENDUM

Evidence, process or context?: examining the factors that drive coverage decisions of pharmaceuticals by health technology assessment bodies in europe

Imatinib Resistance and/or Intolerance in Clinical Practice in Europe: The “Unmet Needs in CML and Ph+ALL” (UNIC) Study

Real-Life Rates of Disease Monitoring in Clinical Practice in Europe: The “Unmet Needs in CML and Ph+ALL” (UNIC) Study

Mycobacterium aviumsubsp. paratuberculosis isolated from wild red deer (Cervus elaphus) in Northern Italy

Mycobacterium avium subsp. paratuberculosis isolated from wild red deer ( Cervus elaphus ) in Northern Italy

Modelling and optimizing the process of learning mathematics

Suchergebnisse filtern